Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 315.76% Upside As of ...
HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it is ...
The controversy over Texas state Rep. James Talarico’s alleged comment about one of his former Democratic opponents has exposed some of the racial divides unfolding in the party's Senate primary, with ...
Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of February 4, 2026, the average one-year price ...
The tense Texas Democratic Senate primary has been roiled by yet another online firestorm after an influencer accused state Rep. James Talarico of calling a former opponent a “mediocre Black man” — a ...
Rachel Accurso, the prominent children’s entertainer known as Ms. Rachel, came under fire after screenshots circulated online that showed her Instagram account liking a comment that read, “Free ...
The children's entertainer says it was an accident. Her critics say it points to a pattern. By Seth Abramovitch Senior Writer Children’s entertainer Rachel Accurso, known to millions of families as Ms ...
Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...
Christina returned to Local 10 in 2019 as a reporter after covering Hurricane Dorian for the station. She is an Edward R. Murrow Award-winning journalist and previously earned an Emmy Award while at ...
Raquel Pacheco began recording on her phone Monday as she opened her front door to the pair of police officers standing outside. They told her they had questions about a Facebook comment she had ...
Scammers are flooding LinkedIn posts this week with fake "reply" comments that appear to come from the platform itself, warning users of bogus policy violations and urging them to visit an external ...
Years ago, New York Times columnist Gail Collins visited The Seattle Times newsroom while in town for a speaking engagement. It was at the height of the establishment of the Doctrine against ...